期刊文献+

脂质体共递药系统用于肿瘤联合治疗的新进展 被引量:6

Recent advances in liposome-based co-delivery systems for combination cancer therapy
下载PDF
导出
摘要 肿瘤联合治疗是临床癌症治疗的常用手段,指通过应用两种或两种以上的药物发挥协同作用从而提高抗癌效果。脂质体是一种药物载体,近年来被广泛用于多种抗癌药物的共递送。本文中,笔者主要介绍脂质体的发展以及脂质体共载体系用于癌症联合治疗的研究进展。 Combination therapy is a commonly used clinical approach for cancer treatment,in which two ormultiple agents are used to produce synergistic effects for enhanced antitcancer efficacy. Liposomes areemerging as drug carriers,and are widely applied for co-delivery of multiple drugs in recent years.In thisreview,we introduce the development of the liposomes and summarize the recent progress in the liposome-based co-delivery systems for combinatorial cancer treatment.
作者 王梦玥 李腾 蒋曙光 莫然 WANG Mengyue;LI Teng;JIANG Shuguang;MO Ran(Center of Advanced Pharmaceuticals and Biomaterials,China Pharmaceutical University,Nanjing 210009,China)
出处 《生物加工过程》 CAS 2018年第5期33-41,共9页 Chinese Journal of Bioprocess Engineering
基金 国家自然科学基金(81673381) 江苏省自然科学基金杰出青年基金(BK20150029)
关键词 脂质体 共递药系统 联合治疗 癌症 生物材料 liposomes co-delivery system combination therapy cancer bio?material
  • 相关文献

参考文献3

二级参考文献72

  • 1叶果,柯爱武,李羲.MRK-16修饰阿霉素免疫脂质体逆转肺癌细胞多药耐药研究[J].现代肿瘤医学,2007,15(6):754-757. 被引量:9
  • 2CHORDIA M D, YUAN H, JAGTAP P G, et al. Synthesis and bioaetivity of 2,4-diacyl analogues of paclitaxel [J]. Bioorg Med Chem, 2001, 9(1): 171-178.
  • 3OJIMA I, SLATER J C, MICHAUD E, et al. Syntheses and structure-activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells [J]. J Med Chem, 1996, 39(20): 3889-3896.
  • 4BHAT L, LIU Y, VICTORY S F, et al. Synthesis and evaluation of paclitaxel C7 derivatives: solution phase synthesis of combinatorial libraries [J]. Bioorg Med Chem Lett, 1998, 8(22): 3181-3186.
  • 5LIU Y B, ALI S M, BOGE T C, et al. A systematic SAR study of C10 modified paclitaxel analogues using a combinatorial approach [J]. Comb Chem High T Scr, 2002, 5(1): 39-48.
  • 6RICE A, LIU Y, MICHAELIS M L, et al. Chemical modification of paclitaxel (Taxol) reduces P-glycoprotein interactions and increases permeation across the blood-brainbarrier in vitro and in situ [J]. J Med Chem, 2005, 48(3): 832-838.
  • 7IIMURA S, UOTO K, OHSUKI S, et al. Orally active docetaxel analogue: synthesis of 10-deoxy-10-C-morpholinoethyl docetaxel analogues [J]. Bioorg Med Chem Lett, 2001, 11(3): 407-410.
  • 8WALKER M A, JOHNSON T D, HUANG S, et al. Synthesis of a novel C-10 spiro-epoxide of paclitaxel [J]. Bioorg Med Chem Lett, 2001, 11(13): 1683-1685.
  • 9TARRANT J G, COOK D, FAIRCHILD C, et al. Synthesis and biological activity of macrocyclic taxane analogues [J]. Bioorg Med Chem Lett, 2004, 14(10): 2555-2558.
  • 10MATESANZ R, BARASOAIN I, YANG C G, et al. Optimization of taxane binding to microtubules: binding affinity dissection and incremental construction of a high-affinity analog of paclitaxel [J]. Chem Biol, 2008, 15(6): 573-585.

共引文献23

同被引文献61

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部